EP2710137
A COMBINATION OF ROSE BENGAL AND ANTI-CTLA4 ANTIBODY FOR USE IN THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.3.2012EP published:
19.9.2018EP application number:
12755115.8
EPO information:
European Patent Register
Max expiry date:
8.3.2032
Title:
A COMBINATION OF ROSE BENGAL AND ANTI-CTLA4 ANTIBODY FOR USE IN THE TREATMENT OF CANCER
Timeline
Today
9.3.2012EP application
19.9.2018EP Publication
Owner
Name:
Provectus Pharmatech, Inc.Address:
10025 Investment Drive, Suite 250, 37932, Knoxville, Tennessee, US
Name:
Pfizer Inc.Address:
235 East 42nd Street, 10017, New York, NY, US
Inventor
Name:
EAGLE, Craig J.Address:
New York, NY, US
Name:
DEES, H. CraigAddress:
Knoxville, TN, US
Name:
WACHTER, Eric A.Address:
Oak Ridge Tennessee, US
Name:
SINGER, JamieAddress:
KnoxvilleTennessee, US
Priority
Number:
201161451395 PDate:
10.3.2011Country:
US
Classification
Categories:
A61K 31/352, A61K 39/395, A61P 35/00